Balili, Quirino B.

HRN: 26-68-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/26/2025
03/05/2025
IV
4.5
Q8
CAP MR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines